Search

Compugen Ltd

Uždarymo kaina

2.32 -2.52

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.37

Max

2.39

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.211

60.549

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+95.4% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-47M

223M

Ankstesnė atidarymo kaina

4.84

Ankstesnė uždarymo kaina

2.32

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-12 23:51; UTC

Cryptocurrency market mixed as Bitcoin dips and Ethereum rises ahead of key U.S. inflation data releases impacting Federal Reserve policy.

2026-07-12 23:51; UTC

Markets brace for key U.S. inflation and retail sales data releases, with potential implications for Federal Reserve policy amid ongoing economic pressures.

2026-07-12 23:51; UTC

Cryptocurrency market shows mixed performance ahead of key U.S. inflation data, as Federal Reserve signals focus on AI in monetary policy.

2026-07-12 23:51; UTC

Cryptocurrency market shows mixed performance ahead of critical U.S. economic data releases that may impact Federal Reserve monetary policy.

2026-07-12 23:51; UTC

Bank of Korea Expected to Maintain Interest Rate at 2.5% Amid Rising Inflation and Economic Uncertainty

2026-07-12 23:51; UTC

China's House Price Index YoY Release on July 15 Expected to Show Continued Decline Amidst Ongoing Property Sector Challenges and Global Economic Uncertainty.

2026-07-12 23:41; UTC

US Import Prices Expected to Decrease by 0.4% Amid Cautious Market Sentiment and Geopolitical Tensions Ahead of Key Economic Data Releases

2026-07-12 23:41; UTC

Housing Starts Data Release on July 17, 2026: Analysts Brace for Weakness Amid High Mortgage Rates and Economic Pressures.

2026-07-12 23:41; UTC

US Export Prices Expected to Rise Amid Inflation Concerns and Geopolitical Tensions Ahead of Key Economic Data Releases

2026-07-12 23:41; UTC

U.S. Building Permits MoM Prel for June 2026 Set to Release Amid Heightened Focus on Housing Trends and Legislative Changes

2026-07-12 23:41; UTC

Upcoming U.S. Housing Starts Data Release on July 17 Expected to Influence Economic Outlook Amid Legislative Changes and Key Macroeconomic Indicators.

2026-07-12 23:41; UTC

U.S. Building Permits Data Release on July 17 Expected to Show Annualized Rate of 1.42 Million Amid Cautious Market Sentiment and Key Macroeconomic Indicators Ahead.

2026-07-12 23:41; UTC

Macro News
Correlated Moves

The US 30Y Treasury Bond Index is lower as capital shifts to technology sectors, with rising oil prices amid U.S.-Iran tensions impacting safe-haven demand.

2026-07-12 23:31; UTC

Australia's NAB Business Confidence Index set for release amid cautious sentiment and global economic uncertainties.

2026-07-12 23:21; UTC

Philadelphia Fed Manufacturing Index Release on July 16 Expected to Show Moderate Optimism Amidst Cautious Market Sentiment and Geopolitical Tensions.

2026-07-12 23:21; UTC

U.S. Retail Sales Expected to Rise 0.3% in June Amid Cautious Optimism and Key Economic Indicators Ahead of Fed Policy Insights

2026-07-12 23:21; UTC

U.S. Retail Sales Ex Autos Expected to Decline 0.1% in June Amid Economic Caution and Geopolitical Tensions

2026-07-12 23:11; UTC

Canada's housing starts data set for July 16, 2026, expected to show resilience with a forecast of 260K units amid positive government initiatives.

2026-07-12 23:01; UTC

NZD/CHF has moved higher in after-market trading, currently 1.22% above its 20-day moving average. No specific news was identified for the price move.

2026-07-12 23:01; UTC

Macro News
Correlated Moves

The U.S. dollar strengthens against major currencies, contributing to a modest after-hours gain in USD/CHF amid rising geopolitical tensions and a higher Dollar Index.

2026-07-12 23:01; UTC

Macro News
Correlated Moves

GBP/USD is trading lower after the U.S. dollar strengthened against major currencies amid geopolitical tensions and anticipation of key macroeconomic data releases.

2026-07-12 23:01; UTC

Macro News

The U.S. dollar rose today, reaching a two-day high against the euro amid geopolitical tensions with Iran affecting shipping route stability.

2026-07-12 23:01; UTC

Market anticipates NY Empire State Manufacturing Index reading of 8.7 amid cautious sentiment ahead of key macroeconomic data releases.

2026-07-12 23:01; UTC

Core PPI for June 2026 set to rise by 0.4% MoM, signaling cautious market sentiment ahead of key economic indicators and Federal Reserve insights.

2026-07-12 23:01; UTC

Market Braces for July 15 PPI Release Amid Anticipated 0.2% Increase and Heightened Volatility from Geopolitical Tensions.

2026-07-12 23:01; UTC

The EUR/HUF is trading higher after-market, reaching a session high earlier. Market focus remains on upcoming U.S. inflation data that may impact Fed policy.

2026-07-12 23:01; UTC

Palladium is trading lower today, continuing a decline since Friday's close. Market focus remains on upcoming U.S. economic data releases.

2026-07-12 23:01; UTC

Macro News
Correlated Moves

Gold prices are lower amid a stronger U.S. dollar and renewed U.S.-Iran military tensions, impacting market sentiment toward safe-haven assets.

2026-07-12 23:01; UTC

EUR/NOK is trading lower in after-market hours, reflecting a decline since Friday's close. The price remains near the midpoint of its one-month range.

2026-07-12 23:01; UTC

Macro News

Copper prices are lower as geopolitical tensions rise amid U.S.-Iran confrontations. Reports of Iraq's oil agreements may further impact market dynamics.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

95.4% į viršų

12 mėnesių prognozė

Vidutinis 4.67 USD  95.4%

Aukščiausias 5 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat